Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Maurizio Benucci »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Maurizio Aric < Maurizio Benucci < Maurizio Cassol  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000089 (2008) Mariangela Manfredi [Italie] ; Maurizio Benucci[The role of interleukin-6 in rheumatoid arthritis].
000535 (2012) Alexander Diamantopoulos [Royaume-Uni] ; Maurizio Benucci ; Stefano Capri ; Wolfgang Berger ; Neil Wintfeld ; Giovanni Giuliani ; Walter RicciardiEconomic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy.
000700 (2013) Fabiola Atzeni [Italie] ; Maurizio Benucci ; Salvatore Sallì ; Sara Bongiovanni ; Laura Boccassini ; Piercarlo Sarzi-PuttiniDifferent effects of biological drugs in rheumatoid arthritis.
000747 (????) Maurizio Benucci ; Mariangela Manfredi ; Gianantonio Saviola ; Piercarlo Sarzi-Puttini ; Fabiola AtzeniChanges in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary results.
000D05 (2014) Maurizio Benucci ; Francesca Meacci ; Mariangela Manfredi ; Francesca Li Gobbi ; Maria Infantino ; Cristian Ricci ; Piercarlo Sarzi-Puttini ; Fabiola Atzeni [Italie]Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?
000D30 (2015) Maurizio Benucci [Italie] ; Francesca Meacci ; Mariangela Manfredi ; Francesca Li Gobbi ; Maria Infantino ; Cristian Ricci ; Piercarlo Sarzi-Puttini ; Fabiola AtzeniCan Tocilizumab Decrease Cartilage Oligomeric Matrix Protein Levels and Disease Activity in Patients with Long-Standing Rheumatoid Arthritis?
000F96 (2015) Diego Sangiorgi [Italie] ; Maurizio Benucci [Italie] ; Carmela Nappi [Italie] ; Valentina Perrone [Italie] ; Stefano Buda [Italie] ; Luca Degli Esposti [Italie]Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis.
000F97 (2016) Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Carlotta Nannini [Italie] ; Emanuele Cassarà [Italie] ; Olga Kaloudi [Italie] ; Ennio Giulio Favalli [Italie] ; Andrea Becciolini [Italie] ; Martina Biggioggero [Italie] ; Maurizio Benucci [Italie] ; Francesca Li Gobbi [Italie] ; Valentina Grossi ; Maria Infantino ; Francesca Meacci ; Mariangela Manfredi ; Serena Guiducci [Italie] ; Silvia Bellando-Randone [Italie] ; Marco Matucci-Cerinic [Italie] ; Rosario Foti [Italie] ; Marcella Di Gangi [Italie] ; Marta Mosca [Italie] ; Chiara Tani [Italie] ; Fabrizio Palmieri [Italie] ; Delia Goletti [Italie]Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
001125 (2016) Maurizio Benucci [Italie] ; Francesca Meacci [Italie] ; Valentina Grossi [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Emanuele Bellio [Italie] ; Valerio Bellio [Italie] ; Francesca Li Gobbi [Italie] ; Laura Bazzichi [Italie] ; Paolo Moscato [Italie] ; Dario Caputo [Italie] ; Gianantonio Saviola [Italie] ; Rossella Talotta [Italie] ; Piercarlo Sarzi-Puttini [Italie] ; Fabiola Atzeni [Italie]Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
001194 (????) Fabiola Atzeni ; Alberto Batticciotto ; Ignazio F. Masala ; Rossella Talotta ; Maurizio Benucci ; Piercarlo Sarzi-PuttiniInfections and Biological Therapy in Patients with Rheumatic Diseases.
001444 (2018) Rossella Talotta [Italie] ; Fabiola Atzeni [Italie] ; Alberto Batticciotto [Italie] ; Maurizio Benucci [Italie] ; Sara Bongiovanni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance.
001553 (2017) Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Carlotta Nannini [Italie] ; Emanuele Cassarà [Italie] ; Olga Kaloudi [Italie] ; Ennio Giulio Favalli [Italie] ; Andrea Becciolini [Italie] ; Maurizio Benucci [Italie] ; Francesca Li Gobbi [Italie] ; Serena Guiducci [Italie] ; Rosario Foti [Italie] ; Marta Mosca [Italie] ; Delia Goletti [Italie]Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
001679 (2017) Maurizio Benucci ; Roberto Ravasio [Italie] ; Arianna DamianiMean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate.
001915 (????) Sergio Iannazzo [Italie] ; Maurizio Benucci [Italie] ; Ennio Giulio Favalli [Italie]Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting.
001B84 (????) Antonella Fioravanti [Italie] ; Sara Tenti [Italie] ; Maria Romana Bacarelli [Italie] ; Arianna Damiani [Italie] ; Francesca Li Gobbi [Italie] ; Francesca Bandinelli [Italie] ; Sara Cheleschi [Italie] ; Mauro Galeazzi [Italie] ; Maurizio Benucci [Italie]Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.
002080 (2019) Maurizio Benucci [Italie] ; Arianna Damiani [Italie] ; Mariangela Manfredi [Italie] ; Maria Infantino [Italie] ; Valentina Grossi [Italie] ; Francesca Li Gobbi [Italie]Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
002485 (2019) Maurizio Benucci [Italie] ; Valentina Grossi [Italie] ; Mariangela Manfredi [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Paolo Moscato [Italie] ; Luigi Cinquanta [Italie] ; Elisa Gremese [Italie] ; Barbara Tolusso [Italie] ; Luca Petricca [Italie] ; Anna Laura Fedele [Italie] ; Stefano Alivernini [Italie] ; Fabiola Atzeni [Italie] ; Giovanni Minisola [Italie] ; Roberto Verna [Italie]Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity
002954 (2020) Maurizio Benucci [Italie] ; Luciana Tramacere [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Valentina Grossi [Italie] ; Arianna Damiani [Italie] ; Francesca Li Gobbi [Italie] ; Maristella Piccininni [Italie] ; Gaetano Zaccara [Italie] ; Massimo Cincotta [Italie]Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies
002C28 (2020) Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie]Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
002C29 (2020) Maurizio Benucci [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Luca Quartuccio [Italie]Old and new antirheumatic drugs for the treatment of COVID-19
002D84 (2020) Maurizio Benucci [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Luca Quartuccio [Italie]Médicaments rhumatologiques pour le traitement de l’infection par le COVID-19☆

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Maurizio Benucci" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Maurizio Benucci" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Maurizio Benucci
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021